Dow Up 0.15% Nasdaq Up 0.12%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
14.44 Up 0.25(1.76%) 9:50AM EDT - Nasdaq Real Time Price
Prev Close:14.19
Open:14.22
Bid:14.31 x 500
Ask:14.39 x 900
1y Target Est:36.50
Beta:3.32
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:14.21 - 14.49
52wk Range:10.76 - 38.84
Volume:80,492
Avg Vol (3m):1,918,270
Market Cap:1.29B
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXUp 1.76%1.29B
DNDNDown 0.67%226.94M
LLYUp 0.18%70.65B
RHHBYDown 0.05%254.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):486.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.31
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback